ArticleClinicoEconomics and outcomes research : CEOR2022

Cost-Effectiveness and Budget Impact Analyses of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia from the Singapore Healthcare System Perspective.

Xiao Jun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.